Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Originally developed to reduce visceral fat, it works by stimulating the natural release of growth hormone
Arrest of 3T3 cells in G1 phase in suspension culture
In the STEP UP clinical trial, participants on the highest dose of Wegovy (7.2mg) lost an average of 20.7% of their body weight over 72 weeks 2
Importantly, not all variants confer increased risk: loss of function variants in HSD17B13, a lipid droplet-associated protein in hepatocytes, have been consistently associated with reduced hepatic inflammation and a lower risk of fibrosis and advanced liver disease [16]
Although this drug class has thought to have a low-risk side effect profile, the risk of developing pancreatitis may be concerning to patients and healthcare professionals
Diabetes is one of the commonest NCD in the world
